1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

  • March 2014
  • 127 pages
  • GlobalData
Report ID: 2225856

Summary

Table of Contents

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

Summary

The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV vaccines were developed and marketed solely to protect against cervical cancer. In recent years the role of HPV in other cancers has been increasingly recognized which has facilitated a shift towards vaccinating a wider population, most significant has been the inclusion of males in routine vaccine recommendations in some countries. The current HPV vaccines market is dominated by one major player, Merck’s Gardasil, with GlaxoSmithKline’s (GSK’s) HPV vaccine Cervarix providing the only competition. The introduction of Merck’s nine-valent vaccine (V503) is set to change the future landscape of the HPV vaccines sector.

There are very low HPV vaccine coverage rates in France and GlobalData expects this to continue throughout the forecast period, especially while the burden of vaccine cost falls partially on the patient. GlobalData anticipates that the low coverage rates for HPV vaccination in Germany will persist throughout the forecast period. Although lower than for other vaccines, coverage rates for HPV vaccination in Italy are higher than for many European countries. Compared with other countries Spain has relatively high coverage rates for HPV vaccination, which GlobalData expects will persist throughout the forecast period. Due to the comprehensive nature of its school-based immunization program, the UK has high HPV vaccine coverage rates.

Scope

- Overview of Prophylactic Human Papillomavirus Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the 5EU including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the 5EU from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the 5EU Prophylactic Human Papillomavirus Vaccines disease market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Prophylactic Human Papillomavirus Vaccines
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of drug performance
- Obtain sales forecast for drugs from 2012-2022 in the 5EU

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers
2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

  • $ 9600
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are ...

2017 Competing in the Global Sexually-Transmitted Disease (STD)Testing Market

2017 Competing in the Global Sexually-Transmitted Disease (STD)Testing Market

  • $ 9600
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

  • $ 6200
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.